<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04972669</url>
  </required_header>
  <id_info>
    <org_study_id>IUNU-PC-105</org_study_id>
    <nct_id>NCT04972669</nct_id>
  </id_info>
  <brief_title>The Study of Electrical Acupuncture Stimulation Therapy for Postprostatectomy Incontinence</brief_title>
  <official_title>The Study of Electrical Acupuncture Stimulation Therapy for Postprostatectomy Incontinence</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      More than 50% patients underwent prostatectomy suffered from postoperative incontinence, and&#xD;
      the effect of pelvic floor muscle training is very limited. Electrical acupuncture&#xD;
      stimulation therapy has been demonstrated to work on other kinds of Urinary Incontinence.&#xD;
      Before this trial, the researchers have conducted pre-experiments where electrical&#xD;
      acupuncture stimulation therapy was conducted for few postprostatectomy Incontinence&#xD;
      patients. On the basis of the preliminary work, this prospective, random control research&#xD;
      aims to verify the safety and effectiveness of electroacupuncture in the treatment of&#xD;
      postprostatectomy Incontinence.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">March 1, 2021</start_date>
  <completion_date type="Anticipated">March 1, 2023</completion_date>
  <primary_completion_date type="Anticipated">March 1, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>change of urine pad quantity for 24 hours after 6 courses compared with baseline</measure>
    <time_frame>3 years</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>change of weight in kilograms of urine pad for 24 hours after 6 courses compared with baseline</measure>
    <time_frame>3 years</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>change of urine pad quantity for 24 hours after 4 courses compared with baseline</measure>
    <time_frame>3 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>change of weight in kilograms of urine pad for 24 hours after 6 courses compared with baseline</measure>
    <time_frame>3 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>changes of The expanded prostate cancer index composite(EPIC) score after 4-6 courses compared with baseline</measure>
    <time_frame>3 years</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">110</enrollment>
  <condition>Postprostatectomy Incontinence</condition>
  <arm_group>
    <arm_group_label>control group</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>sham electroaupuncture</description>
  </arm_group>
  <arm_group>
    <arm_group_label>experimental group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Electroaupuncture</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Electrical Acupuncture Stimulation</intervention_name>
    <description>Participants received acupuncture at bilateral Baliao. After skin disinfection, sterile adhesive pads were placed on bilateral Baliao, and acupuncture needles were inserted through the adhesive pads. Following needle insertion, small, equal manipulations of twirling, lifting, and thrusting were performed on all needles to reach de qi. Electrodes from the electroacupuncture apparatus were attached transversely to the needle handles. The electroacupuncture stimulation lasted for 30 minutes with a continuous wave of 2-15 Hz. Participants received 3 treatment sessions per week (ideally every other day) for 6 consecutive weeks, 18 sessions in total.</description>
    <arm_group_label>experimental group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>sham Acupuncture</intervention_name>
    <description>Participants received sham acupuncture at locations one inch besides bilateral Baliao without needle insertion. Electrodes from the electroacupuncture apparatus were attached transversely to the needle handles. The electroacupuncture stimulation lasted for 30 minutes with a continuous wave of 2-15 Hz. Participants received 3 treatment sessions per week (ideally every other day) for 6 consecutive weeks, 18 sessions in total.</description>
    <arm_group_label>control group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  localized prostate cancer (stage: cT1-cT2, N0, M0)&#xD;
&#xD;
          -  4-6weeks after prostatectomy&#xD;
&#xD;
          -  postprostatectomy prostate specific antigen (PSA) test below cured level&#xD;
&#xD;
          -  incontinence one month after surgery&#xD;
&#xD;
          -  ECOG score:0-1&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  history of neoadjuvant hormonal therapy&#xD;
&#xD;
          -  history of transurethral resection of the prostate (TUPR)&#xD;
&#xD;
          -  history of operation on pelvis&#xD;
&#xD;
          -  history of incontinence before prostatectomy&#xD;
      </textblock>
    </criteria>
    <gender>Male</gender>
    <gender_based>Yes</gender_based>
    <minimum_age>N/A</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Xuefeng Qiu</last_name>
    <phone>13776509416</phone>
    <email>hydewoods@163.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Hongqian Guo</last_name>
    <phone>13605171690</phone>
    <email>dr.ghq@nju.edu.cn</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School</name>
      <address>
        <city>Nanjing</city>
        <state>Jiangsu</state>
        <zip>210000</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hongqian Guo, MD</last_name>
      <phone>8613605171690</phone>
      <email>dr.ghq@nju.edu.cn</email>
    </contact>
    <contact_backup>
      <last_name>Qun Lu, MD</last_name>
      <phone>8615195856020</phone>
      <email>luqun_1989@126.com</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>July 2021</verification_date>
  <study_first_submitted>July 9, 2021</study_first_submitted>
  <study_first_submitted_qc>July 21, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">July 22, 2021</study_first_posted>
  <last_update_submitted>July 21, 2021</last_update_submitted>
  <last_update_submitted_qc>July 21, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">July 22, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School</investigator_affiliation>
    <investigator_full_name>Hongqian Guo</investigator_full_name>
    <investigator_title>Executive officer of Department of Urology, Drum Tower Hospital, Medical School of Nanjing University, Institute of Urology, Nanjing University</investigator_title>
  </responsible_party>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

